Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producingEscherichia coli

Outbreak of hepatitis C virus infection associated with narcotics diversion by an hepatitis C virus–infected surgical technician

(2015) Amy E. Warner et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Activity of temocillin in a murine model of urinary tract infection due toEscherichia coliproducing or not producing the ESBL CTX-M-15

(2015) J. F. Soubirou et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Complete Sequence of a KPC-Producing IncN Multidrug-Resistant Plasmid from an Epidemic Escherichia coli Sequence Type 131 Strain in China

(2014) Liang Chen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration

(2014) P.-F. Laterre et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data

(2014) Thomas P Van Boeckel et al.   LANCET INFECTIOUS DISEASES

Inoculum Effect on the Efficacies of Amoxicillin-Clavulanate, Piperacillin-Tazobactam, and Imipenem against Extended-Spectrum β-Lactamase (ESBL)-Producing and Non-ESBL-Producing Escherichia coli in an Experimental Murine Sepsis Model

(2013) F. Docobo-Pérez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fitness, Stress Resistance, and Extraintestinal Virulence in Escherichia coli

(2013) Alexandre Bleibtreu et al.   INFECTION AND IMMUNITY

In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase

(2013) N. Woodford et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

(2013) L Silvia Munoz-Price et al.   LANCET INFECTIOUS DISEASES

Cefoxitin as an Alternative to Carbapenems in a Murine Model of Urinary Tract Infection Due to Escherichia coli Harboring CTX-M-15-Type Extended-Spectrum β-Lactamase

(2012) Raphaël Lepeule et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United States

(2012) Yohei Doi et al.   CLINICAL INFECTIOUS DISEASES

When Carbapenem-Hydrolyzing β-Lactamase KPC Meets Escherichia coli ST131 in France

(2011) Thierry Naas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Analysis of the Resistome of a Multidrug-Resistant NDM-1-Producing Escherichia coli Strain by High-Throughput Genome Sequencing

(2011) Laurent Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline

(2011) David M. Livermore et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007–09

(2011) Todd A. Davies et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae

(2011) Indran Balakrishnan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Activity of Temocillin against KPC-Producing Klebsiella pneumoniae and Escherichia coli

(2009) J. M. Adams-Haduch et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

(2008) Johann DD Pitout et al.   LANCET INFECTIOUS DISEASES